Outset Medical Files 8-K: Agreement Termination & Financial Obligation
Ticker: OM · Form: 8-K · Filed: Jan 8, 2025 · CIK: 1484612
Sentiment: neutral
Topics: agreement-termination, financial-obligation, corporate-governance
TL;DR
Outset Medical terminated a deal and took on new debt, plus changed its bylaws. Big moves.
AI Summary
Outset Medical, Inc. announced on January 7, 2025, the termination of a material definitive agreement and the creation of a direct financial obligation. The company also filed amendments to its articles of incorporation or bylaws and a change in its fiscal year. Specific details regarding the financial obligations and amendments were not provided in this summary.
Why It Matters
This filing indicates significant corporate actions, including the termination of a key agreement and the incurrence of new debt, which could impact the company's financial health and strategic direction.
Risk Assessment
Risk Level: medium — The termination of a material definitive agreement and the creation of a direct financial obligation suggest potential financial distress or strategic shifts that warrant closer examination.
Key Players & Entities
- Outset Medical, Inc. (company) — Registrant
- January 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39513 (company_id) — SEC File Number
- 20-0514392 (tax_id) — I.R.S. Employer Id
- 3052 ORCHARD DRIVE (address) — Business and Mail Address
- SAN JOSE (city) — Business and Mail City
- CA (state) — Business and Mail State
- 95134 (zip_code) — Business and Mail Zip
- 669-231-8200 (phone_number) — Business Phone
FAQ
What was the nature of the material definitive agreement that was terminated by Outset Medical?
The filing does not specify the nature of the material definitive agreement that was terminated.
What is the direct financial obligation created by Outset Medical?
The filing indicates the creation of a direct financial obligation but does not provide specific details about its nature or amount.
What specific amendments were made to Outset Medical's articles of incorporation or bylaws?
The filing mentions amendments to articles of incorporation or bylaws but does not detail the specific changes.
What is the reason for the change in Outset Medical's fiscal year?
The filing states there was a change in fiscal year but does not provide the reason for this change.
When did Outset Medical officially change its name from Home Dialysis Plus, Ltd.?
Outset Medical, Inc. officially changed its name from Home Dialysis Plus, Ltd. on February 19, 2010 (20100219).
Filing Stats: 1,522 words · 6 min read · ~5 pages · Grade level 13 · Accepted 2025-01-08 16:37:24
Key Financial Figures
- $0.001 — registered Common Stock, par value of $0.001 per share OM The Nasdaq Stock Marke
- $100.0 m — al term loan in the principal amount of $100.0 million, and used the proceeds of such lo
- $100.0 million — al term loan in the principal amount of $100.0 million and issued to Perceptive Credit Holding
- $0.80 — arrant"), at an exercise price equal to $0.80. If the Company draws the delayed draw
- $25.0 m — aws the delayed draw term loan of up to $25.0 million, the Company is required to issue
- $200.00 — ally on the original per share price of $200.00 (plus any such accreted compounded amou
Filing Documents
- d859629d8k.htm (8-K) — 35KB
- d859629dex31.htm (EX-3.1) — 83KB
- d859629dex41.htm (EX-4.1) — 101KB
- 0001193125-25-003545.txt ( ) — 389KB
- om-20250107.xsd (EX-101.SCH) — 3KB
- om-20250107_lab.xml (EX-101.LAB) — 18KB
- om-20250107_pre.xml (EX-101.PRE) — 11KB
- d859629d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits: No. Exhibit 3.1 Certificate of Designation of Preferences, Rights and Limitations of Series A Non-Voting Convertible Preferred Stock 4.1 Warrant Certificate, dated January 8, 2025, issued by Outset Medical, Inc. to Perceptive Credit Holdings IV, LP 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 8, 2025 Outset Medical, Inc. By: /s/ Nabeel Ahmed Name: Nabeel Ahmed Title: Chief Financial Officer